| 000 | 01840 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516072738.0 | ||
| 264 | 0 | _c20120629 | |
| 008 | 201206s 0 0 eng d | ||
| 022 | _a1432-0584 | ||
| 024 | 7 |
_a10.1007/s00277-011-1394-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFaber, Edgar | |
| 245 | 0 | 0 |
_aImatinib trough plasma levels do not correlate with the response to therapy in patients with chronic myeloid leukemia in routine clinical setting. _h[electronic resource] |
| 260 |
_bAnnals of hematology _cJun 2012 |
||
| 300 |
_a923-9 p. _bdigital |
||
| 500 | _aPublication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xanalysis |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 |
_aBiomarkers, Pharmacological _xanalysis |
| 650 | 0 | 4 | _aBlood Chemical Analysis |
| 650 | 0 | 4 | _aClinical Laboratory Techniques |
| 650 | 0 | 4 | _aDiagnostic Tests, Routine |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPiperazines _xanalysis |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aPyrimidines _xanalysis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aFriedecký, David | |
| 700 | 1 | _aMičová, Kateřina | |
| 700 | 1 | _aRožmanová, Sárka | |
| 700 | 1 | _aDivoká, Martina | |
| 700 | 1 | _aJarošová, Marie | |
| 700 | 1 | _aIndrák, Karel | |
| 700 | 1 | _aAdam, Tomáš | |
| 773 | 0 |
_tAnnals of hematology _gvol. 91 _gno. 6 _gp. 923-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00277-011-1394-x _zAvailable from publisher's website |
| 999 |
_c21448135 _d21448135 |
||